Peripheral monocytes of AD patients show increased mRNA expression of NLRP1, NLRP3, PYCARD, caspase-1, IL-1β, and IL-18, and activation of the NLRP1 and NLRP3 inflammasomes [44]. Here, NLRP3 is linked to Alzheimer disease.